Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
---|---|---|---|---|---|---|---|
1. | Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column | Tassaneeyakul, W. | 1988 | ||||
2. | A study of major causes and types of poisoning in Khonkaen, Thailand | Tassaneeyakul, W. Reungsritrakool, W. Sripanyawit, U. Premkamol, A. Prasartthong, W. |
1992 | ||||
3. | High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes | Tassaneeyakul, W. | 1993 | ||||
4. | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism | Tassaneeyakul, W. Tassaneeyakul, W. |
1993 | ||||
5. | Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2 | Tassaneeyakul, W. McManus, M.E. Gelboin, H.V. |
1993 | ||||
6. | Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques | Tassaneeyakul, W. | 1993 | ||||
7. | Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms | Tassaneeyakul, W. McManus, M.E. Tassaneeyakul, W. |
1994 | ||||
8. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 | Tassaneeyakul, W. Tassaneeyakul, W. |
1996 | ||||
9. | Towards Understanding Cytochromes P450 | Wichittra Tassaneeyakul Wongwiwat Tassaneeyakul Khan Kaen Khon Kaen University |
1996 | ||||
10. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice | Tassaneeyakul, W. Tassaneeyakul, W. Vannaprasaht, S. Yamazoe, Y. |
2000 | ||||
11. | Genetic Polymorphism of Cytochrome P450 2C19 | Wichittra Tassaneeyakul Arporn Tawalee Wongwiwat Tassaneeyakul |
2000 | ||||
12. | Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population | Wichittra Tassaneeyakul Arpom Tawalee Veerapol Kukongviriyapan Wongwiwat Tassaneeyakul |
2000 | ||||
13. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. | Tassaneeyakul, W. Tawalee, A. Tassaneeyakul, W. Kukongviriyapan, V. Blaisdell, J.A. Goldstein, J.A. , |
2002 | ||||
14. | Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers | Wongwiwat Tassaneeyakul Arporn Tawalee Watchara Boonsawat Katcharin Phunikom Veerapol Kukongviriyapan Prapawadee Puapairoj Wichittra Tassaneeyakul |
2002 | ||||
15. | Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population | Somrudee Srimartpirom Wongwiwat Tassaneeyakul Veerapol Kukongwiriyapan Wichittra Tassaneeyakul |
2002 | ||||
16. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. | S Srimarthpirom S Reungjui K Chansung A Romphurk W Tassaneeyakul |
2003 | ||||
17. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] | Tassaneeyakul, W. Srimarthpirom, S. Reungjui, S. Chansung, G. Romphruk, A.V. Tassaneeyakul, W. |
2003 | ||||
18. | Prevalence and strain distribution of HPV in cervical cancer patients of northeastern Thailand | W Settheetham-Ishida Y Singto N Kanjanavirojkul P Yuenyao W Tassaneeyakul S Luanratanakorn C Kularbkaew T Ishida |
2003 | ||||
19. | Contamination of aflatoxins in herbal medicinal products in Thailand. | Tassaneeyakul, W. Porasuphatana, S. |
2004 | ||||
20. | Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand | W Settheetham-Ishida Y Singto P Yuenyao W Tassaneeyakul N Kanjanavirojkul T Ishida |
2004 | ||||
21. | Thiopurine S-methyltransferase genetic polymorphism in the Thai population | Srimartpirom, S Tassaneeyakul, W Kukongviriyapan, V Tassaneeyakul, W |
2004 | ||||
22. | Thiopurine S-methyltransferase polymorphism in the Thai population | Tassaneeyakul, W. Kukongviriyapan, V. Tassaneeyakul, W. |
2004 | ||||
23. | Assessment of the CYP1A2 & CYP2E1 activities in thalassemia patients | V Kukongviriyapan N Somparn L Senggunprai U Kukongviriyapan W Tassaneeyakul A Jetsrisuparb |
2005 | ||||
24. | Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma | A Prawan V Kukongviriyapan W Tassaneeyakul C Pairojkul V Bhudhisawasdi |
2005 | ||||
25. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. | K Kittiwattanagul S Vannaprasaht J Kampan A Tawalee P Puapairoj S Tiamkao S Juthagridsada V Kukongviriyapan W Tassaneeyakul |
2005 | ||||
26. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Wichittra Tassaneeyakul Werawath Mahatthanatrakul Kanokporn Niwatananun Kesara Na-Bangchang Arporn Tawalee Nathawut Krikreangsak Utaiwan Cykleng Wongwiwat Tassaneeyakul |
2006 | ||||
27. | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 | V Kukongviriyapan N Phromsopha W Tassaneeyakul U Kukongviriyapan B Sripa V Hahnvajanawong V Bhudhisawasdi |
2006 | ||||
28. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Jitpimolmard, S Sawanyawisuth, K Morakote, N Vejjajiva, A Puntumetakul, M Sanchaisuriya, K Tassaneeyakul, W Tassaneeyakul, W Korwanich, N |
2007 | ||||
29. | ALPHA-LIPOIC ACID INCREASES REACTIVE OXYGEN SPECIES GENERATION AND REDUCED GLUTATHIONE IN AFLATOXINB1-EXPOSED HEPG2 CELL LINE | Nattakorn Rangsoi Supatra Porasuphatana Pramote Mahakunakorn Wongwiwat Tassaneeyakul |
2007 | ||||
30. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 | ||||
31. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 | ||||
32. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 | ||||
33. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 | ||||
34. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | U. Boonsrirat S. Angsuthum S. Vannaprasaht J. Konapurivijit N. Hirankarn W. Tassaneeyakul Y. Avihingsanon |
2008 | ||||
35. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers | W. Tassaneeyakul S. Kanchanawat D. Gaysonsiri S. Vannaprasath R. Paupairoj K. Kittiwattanagul S. K. Tippabhotla A. Khuroo B. K. Panigrahy S. Reyar T. Monif |
2008 | ||||
36. | Herb and Drug Interaction | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Wongwiwat Tassaneeyakul |
2008 | ||||
37. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | P. Tangsucharit J. Kampan S. Kanjanawart D. Gaysonsiri S. Vannaprasaht S. Tiamkao K. Phunikhom S. Simasathiansophon P. Puapairoj W. Tassaneeyakul |
2009 | ||||
38. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Sirivongs, D. Pongskul, C. Makarawate, P. Tassaneeyakul, W. Tassaneeyakul, W. |
2009 | ||||
39. | Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus | Theerada Taesotikul Aimon Somanabandhu Vichien Navinpipatana Sirimas Kanjanawart Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 | ||||
40. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 | ||||
41. | Study on Cytotoxicity and Genotoxicity of Repeatedly Fried Cooking Oils by Cell Culture | Jetana Weerakul Wongwiwat Tassaneeyakul Pramote Mahakunakorn Supattra Porasuphatana |
2009 | ||||
42. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 | ||||
43. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | W. Tassaneeyakul S. Kumar D. Gaysonsiri T. Kaewkamson A. Khuroo P. Tangsucharit K. Phunikhom S. Vannaprasaht S. Kanjanawart N. Rao Thudi R. Jain S. Reyar T. Monif |
2010 | ||||
44. | THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. | Q. Feng S. Vannaprasaht Y. Peng S. Angsuthum Y. Avihingsanon V. C. Yee W. Tassaneeyakul R. M. Weinshilboum |
2010 | ||||
45. | WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST-EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL | R. Somkrua N. Chaiyakunapruk W. Tassaneeyakul |
2010 | ||||
46. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | S. Kanjanawart D. Gaysonsiri P. Tangsucharit S. Vannaprasaht K. Phunikhom T. Kaewkamson N. Wattanachai W. Tassaneeyakul |
2011 | ||||
47. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | N. Namwat J. Puetkasichonpasutha W. Loilome P. Yongvanit A. Techasen A. Puapairoj B. Sripa W. Tassaneeyakul N. Khuntikeo S. Wongkham |
2011 | ||||
48. | Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. | Theerada Taesotikul Weeraya Dumrongsakulchai Nitsupa Wattanachai Vichien Navinpipat Aimon Somanabandhu Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2011 | ||||
49. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Wattanachai, N Polasek, TM Heath, TM Uchaipichat, V Tassaneeyakul, W Tassaneeyakul, W Miners, JO |
2011 | ||||
50. | EVIDENCE SYNTHESIS OF ASSOCIATION OF HLA-B*1502 ALLELE AND CARBAMAZEPINE -INDUCED STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: A SYSTEMATIC REVIEW | W. Tangamornsuksan N. Chaiyakunapruk R. Somkrua M. Lohitnavy W. Tassaneeyakul |
2012 | ||||
51. | Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing | M. S. Hershfield J. T. Callaghan W. Tassaneeyakul T. Mushiroda C. F. Thorn T. E. Klein M. T. M. Lee |
2013 | ||||
52. | SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment | P. Makarawate N. Chaosuwannakit S. Vannaprasaht K. Sawanyawisuth K. Seok Hwee E. Deoon Lee W. Tassaneeyakul |
2013 | ||||
53. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Thachanan Kongpan Surakameth Mahasirimongkol Parinya Konyoung Sirimas Kanjanawart Pansu Chumworathayi Nuanjun Wichukchinda Runglak Kidkeukarun Suphanlinee Preechakul Usanee Khunarkornsiri Warawut Bamrungram Butsaban Supharatwattanakun Piroon Mootsikapun Supanida Kwangsukstid Sukanda Denjanta Suda Vannaprasaht Watcharee Rungapiromnan Wimon Suwankesawong Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 | ||||
54. | Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition | N. Nakkam S. Kanjanawart S. Tiamkao W. Tassaneeyakul |
2015 | ||||
55. | Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin | S. Tiamkao N. Prabmeechai P. Konyoung P. Chumworathayi C. Sukasem T. Kongpan N. Saksit A. Sangviroon S. Vannaprasath S. Kanjanawat N. Wichukchinda S. Mahasirimongkol W. Inunchot N. Chaiyakunapruk W. Tassaneeyakul |
2015 | ||||
56. | The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients | S. Vannaprasaht P. Sirisawat P. Chiewthanakul S. Tiamkao W. Tassaneeyakul |
2015 | ||||
57. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 | ||||
58. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Kongpan, T. Chumworathayi, P. Tiamkao, S. Nakkam, N. Vannaprasaht, S. Mahasirimongkol, S. Tassaneeyakul, W. |
2016 | ||||
59. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 | ||||
60. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 | ||||
61. | Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Niwat Saksit Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Wongwiwat Tassaneeyakul Pansu Chumworathayi Sirimas Kanjanawart Chonlaphat Sukasem Alisara Sangviroon Oranuch Pattanacheewapull Wichittra Tassaneeyakul |
2017 | ||||
62. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 | ||||
63. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Saksit, N Tassaneeyakul, W Nakkam, N Konyoung, P Khunarkornsiri, U Chumworathayi, P Sukasem, C Suttisai, S Piriyachananusorn, N Tiwong, P Chaiyakunapruk, N Sawanyawisuth, K Rerkpattanapipat, T Tassaneeyakul, W |
2017 | ||||
64. | HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population | Nontaya Nakkam Parinya Konyoung Sirimas Kanjanawart Niwat Saksit Thachanan Kongpan Kanyarat Khaeso Usanee Khunarkornsiri Areerat Domsena Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2018 | ||||
65. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 | ||||
66. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 | Count | 24 | 17 | 44 | 8 |
Title | Authors | Year | Publication name | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
1. | Monitoring of cyclosporin in whole blood by reversed-phase liquid chromatography on a butyl column | Tassaneeyakul, W. | 1988 |
Journal of Chromatography B: Biomedical Sciences and Applications C (427), pp. 195-198 |
||||||||
2. | A study of major causes and types of poisoning in Khonkaen, Thailand | Tassaneeyakul, W. Reungsritrakool, W. Sripanyawit, U. Premkamol, A. Prasartthong, W. |
1992 |
Veterinary and Human Toxicology 6 (34), pp. 489-492 |
||||||||
3. | High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes | Tassaneeyakul, W. | 1993 |
Journal of Chromatography B: Biomedical Sciences and Applications 1 (616), pp. 73-78 |
||||||||
4. | Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism | Tassaneeyakul, W. Tassaneeyakul, W. |
1993 |
British Journal of Clinical Pharmacology 6 (36), pp. 521-530 |
||||||||
5. | Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2 | Tassaneeyakul, W. McManus, M.E. Gelboin, H.V. |
1993 |
Journal of Pharmacology and Experimental Therapeutics 1 (265), pp. 401-407 |
||||||||
6. | Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques | Tassaneeyakul, W. | 1993 |
Biochemical Pharmacology 11 (46), pp. 1975-1981 |
||||||||
7. | Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms | Tassaneeyakul, W. McManus, M.E. Tassaneeyakul, W. |
1994 |
Biochemical Pharmacology 10 (47), pp. 1767-1776 |
||||||||
8. | Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene 1 | Tassaneeyakul, W. Tassaneeyakul, W. |
1996 |
Journal of Pharmacology and Experimental Therapeutics 1 (276), pp. 101-108 |
||||||||
9. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice | Tassaneeyakul, W. Tassaneeyakul, W. Vannaprasaht, S. Yamazoe, Y. |
2000 |
British Journal of Clinical Pharmacology 2 (49), pp. 139-144 |
||||||||
10. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population | Tassaneeyakul, W. Tawalee, A. Tassaneeyakul, W. Kukongviriyapan, V. Blaisdell, J.A. Goldstein, J.A. , |
2002 |
Pharmacogenetics 3 (12), pp. 221-225 |
||||||||
11. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C [4] | Tassaneeyakul, W. Srimarthpirom, S. Reungjui, S. Chansung, G. Romphruk, A.V. Tassaneeyakul, W. |
2003 |
Transplantation 1 (76), pp. 265-266 |
||||||||
12. | Contamination of aflatoxins in herbal medicinal products in Thailand | Tassaneeyakul, W. Porasuphatana, S. |
2004 |
Mycopathologia 2 (158), pp. 239-244 |
||||||||
13. | Thiopurine S-methyltransferase polymorphism in the Thai population | Tassaneeyakul, W. Kukongviriyapan, V. Tassaneeyakul, W. |
2004 |
British Journal of Clinical Pharmacology 1 (58), pp. 66-70 |
||||||||
14. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | Tassaneeyakul, W. Kittiwattanagul, K. Vannaprasaht, S. Kampan, J. Tawalee, A. Puapairoj, P. Taimkao, S. Kukongviriyapan, V. Tassaneeyakul, W. |
2005 |
Journal of Pharmacy and Pharmaceutical Sciences 1 (8), pp. 47-53 |
||||||||
15. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Tassaneeyakul, W. Mahatthanatrakul, W. Niwatananun, K. Na-Bangchang, K. Tawalee, A. Krikreangsak, N. Cykleng, U. Tassaneeyakul, W. |
2006 |
Drug metabolism and pharmacokinetics 4 (21), pp. 286-290 |
||||||||
16. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Jitpimolmard, S. Sawanyawisuth, K. Morakote, N. Vejjajiva, A. Puntumetakul, M. Sanchaisuriya, K. Tassaneeyakul, W. Tassaneeyakul, W. |
2007 |
Parasitology Research 6 (100), pp. 1293-1296 |
||||||||
17. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand | Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Sirivongs, D. Pongskul, C. Makarawate, P. Tassaneeyakul, W. Tassaneeyakul, W. |
2009 |
Clinical Therapeutics 7 (31), pp. 1524-1533 |
||||||||
18. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W. Jantararoungtong, T. Tiamkao, S. Vannaprasaht, S. Choonhakarn, C. Pisuttimarn, P. Tassaneeyakul, W. |
2009 |
Pharmacogenetics and Genomics 9 (19), pp. 704-709 |
||||||||
19. | Inhibitory effects of phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: Evidence for CYP3A4 mechanism-based Inhibition | Taesotikul, T. Dumrongsakulchai, W. Wattanachai, N. Tassaneeyakul, W. Tassaneeyakul, W. |
2011 |
Drug Metabolism and Pharmacokinetics 2 (26), pp. 154-161 |
||||||||
20. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Wattanachai, N. Uchaipichat, V. Tassaneeyakul, W. Tassaneeyakul, W. |
2011 |
European Journal of Clinical Pharmacology 8 (67), pp. 815-824 |
||||||||
21. | Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Kongpan, T. Chumworathayi, P. Tiamkao, S. Nakkam, N. Vannaprasaht, S. Mahasirimongkol, S. Tassaneeyakul, W. |
2016 |
Pharmacogenetics and Genomics 5 (26), pp. 225-234 |
||||||||
22. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
International Journal of Clinical Pharmacology and Therapeutics 2 (55), pp. 177-185 |
||||||||
23. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Nakkam, N. Chumworathayi, P. Chaiyakunapruk, N. Sawanyawisuth, K.I. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 7 (27), pp. 255-263 |
||||||||
24. | HLA pharmacogenetic markers of drug hypersensitivity in a Thai population | Nakkam, N Kanjanawart, S. Kongpan, T. Tassaneeyakul, W. |
2018 |
Frontiers in Genetics AUG (9), pp. |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population. | Tassaneeyakul, W Tawalee, A Tassaneeyakul, W Kukongviriyapan, V Blaisdell, J Goldstein, JA Gaysornsiri, D |
2002 |
Pharmacogenetics 3 (12), pp. 221-5 |
|
2. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C. | Tassaneeyakul, W Srimarthpirom, S Reungjui, S Chansung, K Romphruk, A Tassaneeyakul, W |
2003 |
Transplantation 1 (76), pp. 265-6 |
|
3. | Thiopurine S-methyltransferase genetic polymorphism in the Thai population. | Srimartpirom, S Tassaneeyakul, W Kukongviriyapan, V Tassaneeyakul, W |
2004 |
British journal of clinical pharmacology 1 (58), pp. 66-70 |
|
4. | Contamination of aflatoxins in herbal medicinal products in Thailand. | Tassaneeyakul, W Razzazi-Fazeli, E Porasuphatana, S Bohm, J |
2004 |
Mycopathologia 2 (158), pp. 239-44 |
|
5. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. | Tassaneeyakul, W Kittiwattanagul, K Vannaprasaht, S Kampan, J Tawalee, A Puapairoj, P Tiamkao, S Juthagridsada, S Kukongviriyapan, V Tassaneeyakul, W |
2005 |
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 1 (8), pp. 47-53 |
|
6. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations. | Tassaneeyakul, W Mahatthanatrakul, W Niwatananun, K Na-Bangchang, K Tawalee, A Krikreangsak, N Cykleng, U Tassaneeyakul, W |
2006 |
Drug metabolism and pharmacokinetics 4 (21), pp. 286-90 |
|
7. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis. | Jitpimolmard, S Sawanyawisuth, K Morakote, N Vejjajiva, A Puntumetakul, M Sanchaisuriya, K Tassaneeyakul, W Tassaneeyakul, W Korwanich, N |
2007 |
Parasitology research 6 (100), pp. 1293-6 |
|
8. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 |
Pharmacogenetics and genomics 9 (19), pp. 704-9 |
|
9. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. | Vannaprasaht, S Angsuthum, S Avihingsanon, Y Sirivongs, D Pongskul, C Makarawate, P Praditpornsilpa, K Tassaneeyakul, W Tassaneeyakul, W |
2009 |
Clinical therapeutics 7 (31), pp. 1524-33 |
|
10. | Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. | Taesotikul, T Dumrongsakulchai, W Wattanachai, N Navinpipat, V Somanabandhu, A Tassaneeyakul, W Tassaneeyakul, W |
2011 |
Drug metabolism and pharmacokinetics 2 (26), pp. 154-61 |
|
11. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. | Wattanachai, N Polasek, TM Heath, TM Uchaipichat, V Tassaneeyakul, W Tassaneeyakul, W Miners, JO |
2011 |
European journal of clinical pharmacology 8 (67), pp. 815-24 |
|
12. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. | Nakkam, N Tiamkao, S Kanjanawart, S Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Drug metabolism and pharmacokinetics 4 (30), pp. 295-304 |
|
13. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Kongpan, T Mahasirimongkol, S Konyoung, P Kanjanawart, S Chumworathayi, P Wichukchinda, N Kidkeukarun, R Preechakul, S Khunarkornsiri, U Bamrungram, W Supharatwattanakun, B Mootsikapun, P Kwangsukstid, S Denjanta, S Vannaprasaht, S Rungapiromnan, W Suwankesawong, W Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Pharmacogenetics and genomics 8 (25), pp. 402-11 |
|
14. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. | Tassaneeyakul, W Prabmeechai, N Sukasem, C Kongpan, T Konyoung, P Chumworathayi, P Tiamkao, S Khunarkornsiri, U Kulkantrakorn, K Saksit, N Nakkam, N Satapornpong, P Vannaprasaht, S Sangviroon, A Mahasirimongkol, S Wichukchinda, N Rerkpattanapipat, T Tassaneeyakul, W |
2016 |
Pharmacogenetics and genomics 5 (26), pp. 225-34 |
|
15. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. | Saksit, N Tassaneeyakul, W Nakkam, N Konyoung, P Khunarkornsiri, U Chumworathayi, P Sukasem, C Suttisai, S Piriyachananusorn, N Tiwong, P Chaiyakunapruk, N Sawanyawisuth, K Rerkpattanapipat, T Tassaneeyakul, W |
2017 |
Pharmacogenetics and genomics 7 (27), pp. 255-263 |
|
16. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 |
International journal of clinical pharmacology and therapeutics 2 (55), pp. 177-185 |
|
17. | Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population. | Nakkam, N Konyoung, P Kanjanawart, S Saksit, N Kongpan, T Khaeso, K Khunarkornsiri, U Dornsena, A Tassaneeyakul, W Tassaneeyakul, W |
2018 |
Frontiers in genetics (9), pp. 277 |
Title | Authors | Year | Journal title | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
1. | Analysis of the CYP2C19 polymorphism in a North-eastern Thai population | A Tawalee W Tassaneeyakul V Kukongviriyapan J Blaisdell JA Goldstein D Gaysornsiri |
2002 |
PHARMACOGENETICS 3.0 (12.0), pp. 221.0-225.0 |
57 | 0 | 0 | 0 | 0 | 0 | 57 | |
2. | Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C | S Srimarthpirom S Reungjui K Chansung A Romphurk W Tassaneeyakul |
2003 |
TRANSPLANTATION 1.0 (76.0), pp. 265.0-266.0 |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
3. | Prevalence and strain distribution of HPV in cervical cancer patients of northeastern Thailand | W Settheetham-Ishida Y Singto N Kanjanavirojkul P Yuenyao W Tassaneeyakul S Luanratanakorn C Kularbkaew T Ishida |
2003 |
JOURNAL OF CLINICAL VIROLOGY (28.0), pp. S102-S102 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
4. | Contamination of aflatoxins in herbal medicinal products in Thailand | W Tassaneeyakul E Razzazi-Fazeli S Porasuphatana J Bohm |
2004 |
MYCOPATHOLOGIA 2.0 (158.0), pp. 239.0-244.0 |
91 | 0 | 0 | 0 | 0 | 0 | 91 | |
5. | Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand | W Settheetham-Ishida Y Singto P Yuenyao W Tassaneeyakul N Kanjanavirojkul T Ishida |
2004 |
CANCER LETTERS 2.0 (210.0), pp. 205.0-211.0 |
41 | 0 | 0 | 0 | 0 | 0 | 41 | |
6. | Thiopurine S-methyltransferase genetic polymorphism in the Thai population | S Srimartpirom V Kukongviriyapan W Tassaneeyakul |
2004 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 1.0 (58.0), pp. 66.0-70.0 |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
7. | Assessment of the CYP1A2 & CYP2E1 activities in thalassemia patients | V Kukongviriyapan N Somparn L Senggunprai U Kukongviriyapan W Tassaneeyakul A Jetsrisuparb |
2005 |
FASEB JOURNAL 4.0 (19.0), pp. A541-A542 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
8. | Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma | A Prawan V Kukongviriyapan W Tassaneeyakul C Pairojkul V Bhudhisawasdi |
2005 |
EUROPEAN JOURNAL OF CANCER PREVENTION 3.0 (14.0), pp. 245.0-250.0 |
54 | 0 | 0 | 0 | 0 | 0 | 54 | |
9. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | K Kittiwattanagul S Vannaprasaht J Kampan A Tawalee P Puapairoj S Tiamkao S Juthagridsada V Kukongviriyapan W Tassaneeyakul |
2005 |
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 1.0 (8.0), pp. 47.0-53.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
10. | CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations | Wichittra Tassaneeyakul Werawath Mahatthanatrakul Kanokporn Niwatananun Kesara Na-Bangchang Arporn Tawalee Nathawut Krikreangsak Utaiwan Cykleng Wongwiwat Tassaneeyakul |
2006 |
DRUG METABOLISM AND PHARMACOKINETICS 4.0 (21.0), pp. 286.0-290.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
11. | Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2 | V Kukongviriyapan N Phromsopha W Tassaneeyakul U Kukongviriyapan B Sripa V Hahnvajanawong V Bhudhisawasdi |
2006 |
XENOBIOTICA 1.0 (36.0), pp. 15.0-28.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
12. | Albendazole therapy for eosinophilic meningitis caused by Angiostrongylus cantonensis | Suthipun Jitpimolmard Kittisak Sawanyawisuth Nimit Morakote Athasit Vejjajiva Montien Puntumetakul Kanokwan Sanchaisuriya Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul Narumanas Korwanich |
2007 |
PARASITOLOGY RESEARCH 6.0 (100.0), pp. 1293.0-1296.0 |
77 | 0 | 0 | 0 | 0 | 0 | 77 | |
13. | ALPHA-LIPOIC ACID INCREASES REACTIVE OXYGEN SPECIES GENERATION AND REDUCED GLUTATHIONE IN AFLATOXINB1-EXPOSED HEPG2 CELL LINE | Nattakorn Rangsoi Supatra Porasuphatana Pramote Mahakunakorn Wongwiwat Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 150.0-150.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
14. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 87.0-87.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
15. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 219.0-219.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
16. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 269.0-269.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
17. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | U. Boonsrirat S. Angsuthum S. Vannaprasaht J. Konapurivijit N. Hirankarn W. Tassaneeyakul Y. Avihingsanon |
2008 |
LUPUS 2.0 (17.0), pp. 132.0-134.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
18. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers | W. Tassaneeyakul S. Kanchanawat D. Gaysonsiri S. Vannaprasath R. Paupairoj K. Kittiwattanagul S. K. Tippabhotla A. Khuroo B. K. Panigrahy S. Reyar T. Monif |
2008 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 3.0 (46.0), pp. 151.0-156.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
19. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | P. Tangsucharit J. Kampan S. Kanjanawart D. Gaysonsiri S. Vannaprasaht S. Tiamkao K. Phunikhom S. Simasathiansophon P. Puapairoj W. Tassaneeyakul |
2009 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 10.0 (47.0), pp. 638.0-642.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
20. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Suda Vannaprasaht Susothorn Angsuthum Yingyos Avihingsanon Dhavee Sirivongs Cholatip Pongskul Pattarapong Makarawate Kearkiat Praditpornsilpa Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 |
CLINICAL THERAPEUTICS 7.0 (31.0), pp. 1524.0-1533.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
21. | Inhibition- and Mechanism-based Inactivation of Human CYP3A4 BY Phyllanthus amarus | Theerada Taesotikul Aimon Somanabandhu Vichien Navinpipatana Sirimas Kanjanawart Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 39.0-39.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
22. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Wichittra Tassaneeyakul Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Somsak Tiamkao Usanee Khunarkornsiri Pachadaporn Chucherd Parinya Konyoung Suda Vannaprasaht Charoen Choonhakarn Pornrith Pisuttimarn Alisara Sangviroon Wongwiwat Tassaneeyakul |
2009 |
PHARMACOGENETICS AND GENOMICS 9.0 (19.0), pp. 704.0-709.0 |
345 | 0 | 0 | 0 | 0 | 0 | 345 | |
23. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 253.0-254.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
24. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | W. Tassaneeyakul S. Kumar D. Gaysonsiri T. Kaewkamson A. Khuroo P. Tangsucharit K. Phunikhom S. Vannaprasaht S. Kanjanawart N. Rao Thudi R. Jain S. Reyar T. Monif |
2010 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 9.0 (48.0), pp. 614.0-620.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
25. | THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. | Q. Feng S. Vannaprasaht Y. Peng S. Angsuthum Y. Avihingsanon V. C. Yee W. Tassaneeyakul R. M. Weinshilboum |
2010 |
CLINICAL PHARMACOLOGY & THERAPEUTICS (87.0), pp. S6-S6 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
26. | WHAT COST OF HLA-B*5801 GENOTYPING WOULD BE COST-EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND: ANALYSES USING A DECISION-ANALYTIC MODEL | R. Somkrua N. Chaiyakunapruk W. Tassaneeyakul |
2010 |
VALUE IN HEALTH 7.0 (13.0), pp. A564-A565 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
27. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | S. Kanjanawart D. Gaysonsiri P. Tangsucharit S. Vannaprasaht K. Phunikhom T. Kaewkamson N. Wattanachai W. Tassaneeyakul |
2011 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 8.0 (49.0), pp. 525.0-530.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
28. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | N. Namwat J. Puetkasichonpasutha W. Loilome P. Yongvanit A. Techasen A. Puapairoj B. Sripa W. Tassaneeyakul N. Khuntikeo S. Wongkham |
2011 |
JOURNAL OF GASTROENTEROLOGY 5.0 (46.0), pp. 664.0-675.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
29. | Inhibitory Effects of Phyllanthus amarus and Its Major Lignans on Human Microsomal Cytochrome P450 Activities: Evidence for CYP3A4 Mechanism-Based Inhibition | Theerada Taesotikul Weeraya Dumrongsakulchai Nitsupa Wattanachai Vichien Navinpipat Aimon Somanabandhu Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2011 |
DRUG METABOLISM AND PHARMACOKINETICS 2.0 (26.0), pp. 154.0-161.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
30. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Nitsupa Wattanachai Thomas M. Polasek Tahlia M. Heath Verawan Uchaipichat Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul John O. Miners |
2011 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 8.0 (67.0), pp. 815.0-824.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
31. | EVIDENCE SYNTHESIS OF ASSOCIATION OF HLA-B*1502 ALLELE AND CARBAMAZEPINE -INDUCED STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS: A SYSTEMATIC REVIEW | W. Tangamornsuksan N. Chaiyakunapruk R. Somkrua M. Lohitnavy W. Tassaneeyakul |
2012 |
VALUE IN HEALTH 7.0 (15.0), pp. A640-A640 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
32. | Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing | M. S. Hershfield J. T. Callaghan W. Tassaneeyakul T. Mushiroda C. F. Thorn T. E. Klein M. T. M. Lee |
2013 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 2.0 (93.0), pp. 153.0-158.0 |
134 | 0 | 0 | 0 | 0 | 0 | 134 | |
33. | SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment | P. Makarawate N. Chaosuwannakit S. Vannaprasaht K. Sawanyawisuth K. Seok Hwee E. Deoon Lee W. Tassaneeyakul |
2013 |
EUROPEAN HEART JOURNAL (34.0), pp. 424.0-424.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
34. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions | Thachanan Kongpan Surakameth Mahasirimongkol Parinya Konyoung Sirimas Kanjanawart Pansu Chumworathayi Nuanjun Wichukchinda Runglak Kidkeukarun Suphanlinee Preechakul Usanee Khunarkornsiri Warawut Bamrungram Butsaban Supharatwattanakun Piroon Mootsikapun Supanida Kwangsukstid Sukanda Denjanta Suda Vannaprasaht Watcharee Rungapiromnan Wimon Suwankesawong Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
PHARMACOGENETICS AND GENOMICS 8.0 (25.0), pp. 402.0-411.0 |
39 | 1 | 0 | 0 | 0 | 0 | 40 | |
35. | Genetic Determinants of Antiplatelet Aggregation Response to Clopidogrel Under Steady State Condition | N. Nakkam S. Kanjanawart S. Tiamkao W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 11.0-11.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
36. | Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin | S. Tiamkao N. Prabmeechai P. Konyoung P. Chumworathayi C. Sukasem T. Kongpan N. Saksit A. Sangviroon S. Vannaprasath S. Kanjanawat N. Wichukchinda S. Mahasirimongkol W. Inunchot N. Chaiyakunapruk W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 5.0-5.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
37. | The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients | S. Vannaprasaht P. Sirisawat P. Chiewthanakul S. Tiamkao W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 13.0-14.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
38. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
DRUG METABOLISM AND PHARMACOKINETICS 4.0 (30.0), pp. 295.0-304.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
39. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Wichittra Tassaneeyakul Napat Prabmeechai Chonlaphat Sukasem Thachanan Kongpan Parinya Konyoung Pansu Chumworathayi Somsak Tiamkao Usanee Khunarkornsiri Kongkiat Kulkantrakorn Niwat Saksit Nontaya Nakkam Patompong Satapornpong Suda Vannaprasaht Alisara Sangviroon Surakameth Mahasirimongkol Nuanjun Wichukchinda Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2016 |
PHARMACOGENETICS AND GENOMICS 5.0 (26.0), pp. 225.0-234.0 |
65 | 0 | 0 | 0 | 0 | 0 | 65 | |
40. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Kutcharin Phunikhom Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2017 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 2.0 (55.0), pp. 177.0-185.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
41. | Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions | Niwat Saksit Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Wongwiwat Tassaneeyakul Pansu Chumworathayi Sirimas Kanjanawart Chonlaphat Sukasem Alisara Sangviroon Oranuch Pattanacheewapull Wichittra Tassaneeyakul |
2017 |
JOURNAL OF IMMUNOLOGY RESEARCH (), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
42. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S85-S86 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
43. | Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population | Niwat Saksit Wichittra Tassaneeyakul Nontaya Nakkam Parinya Konyoung Usanee Khunarkornsiri Pansu Chumworathayi Chonlaphat Sukasem Sumitra Suttisai Napacha Piriyachananusorn Pawinee Tiwong Nathorn Chaiyakunapruk Kittisak Sawanyawisuth Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2017 |
PHARMACOGENETICS AND GENOMICS 7.0 (27.0), pp. 255.0-263.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
44. | HLA Pharmacogenetic Markers o Drug Hypersensitivity in a Thai Population | Nontaya Nakkam Parinya Konyoung Sirimas Kanjanawart Niwat Saksit Thachanan Kongpan Kanyarat Khaeso Usanee Khunarkornsiri Areerat Domsena Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2018 |
FRONTIERS IN GENETICS (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | Towards Understanding Cytochromes P450 | Wichittra Tassaneeyakul Wongwiwat Tassaneeyakul Khan Kaen Khon Kaen University |
1996 |
Thai Journal of Pharmacology (18), pp. 43-65 |
|
2. | Genetic Polymorphism of Cytochrome P450 2C19 (CYP2CL9) in The Northeastern Thai Population | Wichittra Tassaneeyakul Arpom Tawalee Veerapol Kukongviriyapan Wongwiwat Tassaneeyakul |
2000 |
Thai Journal of Pharmacology Supplement 1 (22), pp. S79 |
|
3. | Genetic Polymorphism of Cytochrome P450 2C19 | Wichittra Tassaneeyakul Arporn Tawalee Wongwiwat Tassaneeyakul |
2000 |
Thai Journal of Pharmacology (22 No 2), pp. 121-136 |
|
4. | Genetic Polymorphism of Thiopurine S-Methyltransferase in a Northeastern Thai Population | Somrudee Srimartpirom Wongwiwat Tassaneeyakul Veerapol Kukongwiriyapan Wichittra Tassaneeyakul |
2002 |
Thai Journal of Pharmacology Supplement 1 (24), pp. 137 |
|
5. | Bioequivalence Study of Ceftazidime by Intramuscular Administration in Healthy Thai Volunteers | Wongwiwat Tassaneeyakul Arporn Tawalee Watchara Boonsawat Katcharin Phunikom Veerapol Kukongviriyapan Prapawadee Puapairoj Wichittra Tassaneeyakul |
2002 |
Srinagarind Medical Journal (17 No 4), pp. 254-260 |
|
6. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 |
Srinagarind Medical Journal (22 No 1), pp. 16-23 |
|
7. | Herb and Drug Interaction | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Wongwiwat Tassaneeyakul |
2008 |
Srinagarind Medical Journal (23 No 2), pp. 223-228 |
|
8. | Study on Cytotoxicity and Genotoxicity of Repeatedly Fried Cooking Oils by Cell Culture | Jetana Weerakul Wongwiwat Tassaneeyakul Pramote Mahakunakorn Supattra Porasuphatana |
2009 |
Isan Journal of Pharmaceutical Sciences (5 No 3), pp. 235-242 |
Title | Authors | NRIIS type | Year | NRIIS Scholarship |
---|